A novel class of self-complementary AAV vectors with multiple advantages based on cceAAV lacking mutant ITR.
Journal Information
Full Title: Mol Ther Methods Clin Dev
Abbreviation: Mol Ther Methods Clin Dev
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Medicine, Research & Experimental
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declaration of interests W.X. holds equity in Ivygen Corporation and Nikegen LLC. Two of the authors (B.E.D and M.F.J) are shareholders in Megadalton Solutions, a company that is engaged in commercializing CDMS. B.E.D is an employee of Megadalton Solutions and MFJ is a consultant for Waters."
"This work was supported by grants from the 10.13039/100000002NIH (U54HL142019 and P01HL160472). D.A.F. is supported by 10.13039/100000002NIH T32HL007910."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025